Clinical laboratory tests play a crucial role in making sure patients get appropriate care, yet many small labs and clinics in low resource settings cannot afford the instruments needed to provide these tests. Research on a novel fingerprick test that can perform all common clinical diagnostics could help to expand access to basic medical testing in the developing world, and will be featured at the 2015 AACC Annual Meeting & Clinical Lab Expo.
Public health experts estimate that approximately one third of the world’s population does not have adequate access to quality healthcare due to a range of barriers, from limited geographic accessibility to a lack of affordable services. Clinical laboratories in particular are poorly outfitted and sparsely distributed in low-income countries, and few primary healthcare centers in these regions are located within reach of a well-equipped and staffed lab. So-called point-of-care testing devices that are portable and do not require lab support could improve access to testing in underserved areas. However, multiple point-of-care instruments would be required to run the full spectrum of common clinical tests, and this equipment is often expensive.
At AACC’s 2015 Annual Meeting, researchers from DiaSys Diagnostics India in Mumbai will present the first point-of-care device, named QDx InstaLab, that can perform all of the clinical tests that labs routinely order as part of yearly physicals to evaluate organ function and check for conditions such as diabetes, liver disease, and kidney disease. Additionally, the QDx InstaLab can test cholesterol levels to screen for risk of heart disease or to monitor treatment for it, and can screen for bleeding problems or monitor treatment for inappropriate blood clotting as well. To run these numerous tests, the device analyzes a few drops of blood from a fingerprick using inexpensive microfluidic cartridge technology together with novel nanomaterial-based plastic electrochemical biosensors. It provides results in 3 to 10 minutes or less.
To evaluate QDx InstaLab’s accuracy, the researchers performed each of its tests on 40 to 70 patient blood samples and compared the results with those of standard laboratory instruments. Through this, they found that the tests run on QDx InstaLab have a coefficient of variation < 3%, an R² value > 0.95, and an interference bias < 10%, which signifies that the QDX InstaLab is reliable and meets all the performance specifications of a lab.
The Latest on: Point-of-care testing devices
via Google News
The Latest on: Point-of-care testing devices
- Health in Your Hands: How Your Phones Double Up as Medical Devices on April 17, 2019 at 10:41 pm
This affordable, portable ultrasound device works with a smartphone ... The small accessory or dongle easily connects to a smartphone to obtain blood test results. This can provide point-of-care ... […]
- Point of Care (POC) Diagnostic 2019 Global Market Demand, Growth Opportunities and Top Key Players Analysis Report on April 17, 2019 at 1:23 pm
Emerging technological advancements in biosensors, smartphones, wearable devices and ... 5.2. Global Point-Of-Care Diagnostics Market, by Cardiometabolic Testing. 5.3. Global Point-Of-Care ... […]
- Fingerprick PSA Test Has In-Office Results in 12 Minutes on April 17, 2019 at 11:34 am
thanks to a novel device recently approved by the US Food and Drug Administration. The Sangia Total PSA Test (OPKO Diagnostics) is the first test that can provide PSA results at the point of care ... […]
- Interviews with STI patients provide guidance for point-of care testing on April 17, 2019 at 6:21 am
A study of patient opinions and expectations about the potential use of point of care tests (POCTs ... need for a second or third visit after lab testing, some patients were doubtful about ... […]
- Global Point of Care Diagnostics/Testing Market Size, Share & Trends Analysis Report, 2019-2025 - ResearchAndMarkets.com on April 17, 2019 at 4:54 am
which in turn drives adoption of point of care diagnostic/testing products. Lack of skilled professionals or medical personnel with limited training especially in diagnostics can also easily use these ... […]
- Point of Care Testing Market to Witness Huge Growth by 2025 | Abbott, Roche, Siemens, Danaher on April 16, 2019 at 10:24 pm
... Report Sample:- @: https://www.htfmarketreport.com/sample-report/1592307-global-point-of-care-testing-market-6 Market Trend Rising usage of home based POC devices Rising in the number of approvals ... […]
- Point of Care Testing Market outlook with industry review and forecasts on April 16, 2019 at 5:01 am
The use of point of care testing devices in nephrology testing is projected to grow at a CAGR of 7.4% during the estimation period. Increasing incidence of kidney failure and kidney diseases will ... […]
- Biosense: Low-cost medical diagnostic devices, for rural doctors on April 16, 2019 at 2:39 am
The device weighs less than 300 g and the hemoglobin test result is displayed in about one minute ... Since we are catering to the point-of-care centres, the process needs to be extremely simple since ... […]
- Global Point of Care Blood Gas and Electrolyte Market will Reach the valuation of USD 2,543.1 million by 2023 on April 15, 2019 at 4:35 am
and brisk test, and help to enhance emergency clinic tasks. This new innovation gives smaller handheld gadgets a headway in the diagnostic sensors. The global point of care blood gas and electrolyte ... […]
- Microfluidic Devices Market Analysis by Top Companies, New Technology - P&S Intelligence on April 15, 2019 at 1:52 am
The market of microfluidic devices is gaining significant importance due to growing R&D investment in life sciences, pharmaceuticals, and increasing point of care testing demand. The global market for ... […]
via Bing News